Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) is -39.76% lower on its value in year-to-date trading and has touched a low of $22.64 and a high of $53.96 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMPH stock was last observed hovering at around $23.58 in the last trading session, with the day’s loss setting it -0.38%.
Currently trading at $23.2, the stock is -6.62% and -6.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing -1.61% at the moment leaves the stock -33.57% off its SMA200. AMPH registered -37.52% loss for a year compared to 6-month loss of -37.02%.
The stock witnessed a -10.80% gain in the last 1 month and extending the period to 3 months gives it a -16.55%, and is 0.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.49% over the week and 3.04% over the month.
Amphastar Pharmaceuticals Inc (AMPH) has around 2028 employees, a market worth around $1.09B and $730.66M in sales. Current P/E ratio is 8.42 and Fwd P/E is 6.61. Profit margin for the company is 19.38%. Distance from 52-week low is 2.47% and -57.00% from its 52-week high. The company has generated returns on investments over the last 12 months (10.15%).
The EPS is expected to shrink by -19.13% this year
The shares outstanding are 47.67M, and float is at 34.58M with Short Float at 11.80%.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.94 million shares valued at $237.7 million. The investor’s holdings represent 12.1507 of the AMPH Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.67 million shares valued at $106.91 million to account for 5.4652 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 1.94 million shares representing 3.9765 and valued at over $77.79 million, while TD ASSET MANAGEMENT INC holds 3.4587 of the shares totaling 1.69 million with a market value of $67.66 million.
Amphastar Pharmaceuticals Inc (AMPH) Insider Activity
The most recent transaction is an insider sale by Petersen Floyd F., the company’s Director. SEC filings show that Petersen Floyd F. sold 500 shares of the company’s common stock on Jul 02 ’25 at a price of $23.47 per share for a total of $11734.0. Following the sale, the insider now owns 77531.0 shares.
Still, SEC filings show that on Jun 02 ’25, Petersen Floyd F. (Director) disposed off 500 shares at an average price of $25.67 for $12835.0. The insider now directly holds 72,909 shares of Amphastar Pharmaceuticals Inc (AMPH).
